Glypican-3, a novel prognostic marker of hepatocellular cancer, is related with postoperative metastasis and recurrence in hepatocellular cancer patients

References

Page 1

	Year	Citations
Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma Mariana Capurro, Ian R. Wanless, Morris Sherman, Gastroenterology HepatologyNovel SerumHistopathologyPathologyHepatotoxicity	2003	893
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome Giuseppe Pilia, Rhiannon M. Hughes‐Benzie, Alex MacKenzie, Nature Genetics Developmental BiologySimpson-golabi-behmel Overgrowth SyndromeSomatic VariantHuman GrowthGenetic Disorder	1996	762
Glypican-3 Promotes the Growth of Hepatocellular Carcinoma by Stimulating Canonical Wnt Signaling Mariana Capurro, Yun‐Yan Xiang, Corrinne G. Lobe, Cancer Research ImmunologyPathologyCancer BiologyTumor BiologySignaling Pathway	2005	461
Glypican-3 as a Serum Marker for Hepatocellular Carcinoma Mariana Capurro, Jorge Filmus Cancer Research	2005	433
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker Tetsuya Nakatsura, Yoshihiro Yoshitake, Satoru Senju, Biochemical and Biophysical Research Communications OncologyHepatologyHuman Hepatocellular CarcinomaMedicineHistopathology	2003	428
Glypican-3–Deficient Mice Exhibit Developmental Overgrowth and Some of the Abnormalities Typical of Simpson-Golabi-Behmel Syndrome Danielle F. Cano-Gauci, Howard H. Song, Huiling Yang, The Journal of Cell Biology	1999	332
Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma Yoshitaka Hippo, Kiyotaka Watanabe, Akira Watanabe, Cancer Research	2004	294
Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders Z-W Zhu Gut	2001	287
Glypican‐3 expression is correlated with poor prognosis in hepatocellular carcinoma Hirofumi Shirakawa, Hitomi Suzuki, Manami Shimomura, Cancer Science	2009	275
Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution. Hey‐Chi Hsu, Wen‐Fang Cheng, Po-Lin Lai PubMed Differential Display MethodPathologyCancer BiologyTumor BiologyTranscript Mxr7	1997	242

Page 1